Anika Therapeutics, Inc.
ANIK$207M
Micro CapNASDAQSurgical & Medical Instruments & Apparatus🇺🇸North AmericaBEDFORD288 employees
Drugs in Pipeline
2
Phase 3 Programs
2
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
ANIK News
Catalyst Timeline
0 upcoming, 1 past
No catalysts found.
Drug Pipeline
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Cingal | Phase 3 | Osteoarthritis, Knee | - | - |
Triamcinolone Hexacetonide | Phase 3 | Knee Osteoarthritis | - | - |
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply